Lab Box

Lab Box’s stated strategy spans seed, early-stage, growth, and buyout investments. This means the firm can participate in a company’s first outside equity round and remain involved through control-oriented later-stage transactions. Whether the firm runs dedicated vehicles for each stage or deploys opportunistically is not publicly disclosed.

The firm’s legal structure is not detailed in public records. Given its Brussels headquarters and private equity registration, it likely operates as a Belgian management company or an alternative investment fund manager. Without named principals or regulated filings, the structure could also reflect a private investment vehicle for a specific family or group.

No. There is no public disclosure of Lab Box’s investor base, fundraising activity, or sponsorship. For allocators, this absence means the firm would require direct inquiry to determine alignment, concentration, or potential conflicts.

Lab Box is headquartered in Brussels and its website domain targets a European audience. The firm likely prioritizes Belgian and pan-European opportunities, though no specific country allocations, regional offices, or cross-border deal references are publicly available to confirm this.

The firm does not publicly name its founders, managing partners, or investment committee members. For due-diligence purposes, allocators or co-investors would need to obtain this information directly, as no professional biographical profiles or regulatory filings identifying key persons are currently accessible.